shr7390
Showing 1 - 4 of 4
Metastatic Castration-resistant Prostate Cancer Trial in Nanjing (SHR7390)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- SHR7390
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Feb 19, 2022
Breast Cancer, Metastatic Cancer Trial in Shanghai (SHR7390, Famitinib, SHR3162)
Recruiting
- Breast Cancer
- Metastatic Cancer
- SHR7390
- +14 more
-
Shanghai, Shanghai, ChinaCancer Hospital Affiliated to Fudan University
Jul 22, 2022
Solid Tumor Trial in Guangzhou (SHR7390, SHR-1210, SHR3162)
Unknown status
- Solid Tumor
- SHR7390
- +2 more
-
Guangzhou, Guangdong, ChinaThe Cancer Center,Sun Yat-sen University
Feb 25, 2019
Solid Tumor Trial in Guangzhou (SHR7390)
Unknown status
- Solid Tumor
- SHR7390
-
Guangzhou, Guangdong, ChinaThe Cancer Center,Sun Yat-sen University
Jan 14, 2019